Behind NimaGen. A great Team of People

Team

Meet our Team

NimaGen, based in Nijmegen The Netherlands, was founded in 2011 under the Biolegio Holding by Ruud van der Steen (CEO Biolegio) and Joop Theelen (former Application- and Product Development Scientist at Applied Biosystems).

Our resourceful specialists are dedicated to delivering premium quality products and services to DNA sequencing laboratories around the globe, with an emphasis on both proven and innovative solutions for Capillary Electrophoresis (Sanger Sequencing and Fragment Analysis), Nucleic Acid Extraction, Cleanup and Size Selection, as well as Next-generation Sequencing powered by patented Reverse Complement PCR technology.

Anna Krymchenko

Distributor and Product Marketing Manager

Ruud van der Steen MSc

Owner / Chief Executive Officer (CEO)

Joop Theelen BSc

Co-founder / Chief Scientific Officer (CSO)

Rogier van Otterlo MBA BSc

Chief Commercial Officer (CCO)

Steven Garside BSc

Account Manager UK & Ireland / Business Development Manager B2B

Gerrit Volkmann PhD

Account Manager DACH / Distributor Manager

Kees Beers MSc

Account Manager BeNeLux

Pieter van Oers MSc

Senior Business Development Manager Forensics

Eva Janssen-Megens MSc

Laboratory Manager / Senior Research Technician NGS

Simon van Reijmersdal BSc

Team Leader R&D Laboratory / Senior Research Technician NGS

Rowenna Bijl BSc

Laboratory Technician NGS / QA

Erik de Jong BSc

Laboratory Technician NGS / QA

Faria Sidhu

Customer Service and Order Management

Nathalie Willemse

Finance Administrative Assistant

Mariana Piedade BSc

Laboratory Technician Sanger Sequencing

Constantin Paun PhD

Operations Manager

Melanie Arts MSc

Research and Development Scientist Forensics

Katelyn Richards MSc

Marketing Specialist

Anja Pen PhD

Distributor Channel Manager
Product news

Latest news

News | 27.02.24

BSM 2024 (Belgian Society for Microbiology) Attendance Announcement

Come meet the NimaGen team on March 8th, 2024 in Brussels, Belgium to learn all about the Next Revolution in Microbial NGS! We offer a full workflow solution for Sanger Sequencing and Fragment Analysis, as well as Reverse Complement PCR powered EasySeq™ NGS Library Prep kits for Bacterial Identification (V1-V9) or Microbiome (V3, V4) 16S rRNA analysis on illumina® or Full-Length 16S on Oxford Nanopore Technologies (ONT) platforms.
News | 08.01.24

NimaGen's 2023 Highlights ReCAPPed!

NimaGen had a great 2023 and were looking forward to an even better 2024!    NimaGen’s 2023 ReCAPPed™ (Yes, this a pun on our product name):  Our New Building and Facilities:  We kicked off 2023 by moving into our new building with state-of-the-art laboratory and production spaces, as well as comfortable office and meeting spaces! Our NimaGen Grand Opening party in May was an exciting event celebrated by all to commemorate such a momentous occasion; it was also attended by our local major of Nijmegen!            Our New Reverse Complement PCR Sequencing Kits:  From there, we spent the year developing several innovative and exciting new Reverse-Complement PCR sequencing kits for our application areas in Forensics, Microbiology and Infectious Disease and Human Genetics!      Distributors, Partnerships and Collaborations In 2023, NimaGen gained 15 partnerships around the world that help support our expanding product portfolio! From the far reaches of Barcode Biosciences in India to our neighboring country France supported by Dominique Dutscher SAS, as well as strategic collaborations with partnerships in North American with NicheVision for our Forensics portfolio, we desire to help our customers in every cornerstone of the world. Together, we will continue creating shared value!    Customer Experience Survey Rating At the end of 2023, active NimaGen customers received a customer experience survey with an average score of >8/10!. NimaGen responsiveness, solutions focus, personal interaction and product value were highly rated by both customers and distributors. We are grateful for the feedback we received and will continue to strive to continue improve our customer service, quality products and continued innovation that supports  research globally!    Continued ISO 90001 and 13485 Certification  NimaGen proudly continues to maintain its ISO 90001 and ISO 13485 certification. ISO 90001 is a globally recognized standard for quality management that ensures high-level customer service, ongoing optimization and continued process improvement. ISO 13485 is an international standard that specifies strict requirements for quality and competence in a medical device organization, including biotechnology companies, thus ensuring that we are providing high-quality reagents and products.  Congress and Event Attendance:  NimaGen attended several events around the world in 2023! Some conferences were local to the Netherlands such as Dutch Society of Medical Microbiology and the Royal Dutch Society of Microbiology (KNVM NVMM)  or our very own NimaGen Distributor Meeting here in Nijmegen! Other conferences were  within Europe, such as European Society of Clinical Microbiology and Infectious Diseases (ECCMID) in Denmark and the European Society of Human Genetics (ESHG) in Scotland. We also attended many international ones such as International Association of Forensic Sciences (IAFS) in Australia and the International Symposium on Human Identification (ISHI) for Forensics and the American Society for Human Genetics (ASHG) in the U.S.A!  Local: KNVM NVMM 2023 – Arnhem, The Netherlands    NimaGen Distributor Meeting 2023 - Creating Shared Value with our Partners  Europe: ECCMID 2023 – Copenhagen, Denmark   ESHG 2023 – Edinburgh, Scotland    International: IAFS 2023 – Sydney, Australia         ISHI 2023 – Denver, CO USA ASHG 2023 – Washington, D.C. USA             
News | 12.12.23

PT. Indolab Utama (Indonesia): Welcome to the NimaGen Distributor Network!

NimaGen is happy to announce the collaboration with @PT. Indolab Utama. Indolab Utama focusses on Research Institutes, Food and Beverage Industry, Pharmaceutical Industry, Hospital and Universities in the Indonesian market. They have supported several NimaGen users for some time already and we have now strengthened the partnership with an official distributorship. We look forward to working with Indolab Utama to support the customers in Indonesia better.